Weekly Fund Digest - March 18, 2026 | VC & PE Form D Filings

Note: "Amount Raised" reflects the total offering amount disclosed in SEC Form D filings. Funds reporting $0 are excluded from this digest. AUM data is sourced from Form ADV filings where available.

Venture Capital

Top by Amount Raised

Fund I, a series of Consortium, LP filed for $5.0 million from their LYNNWOOD, WA headquarters, fund I by Unanimous Capital is an early-stage venture fund focused on investing in US-based companies with bold ideas and profound potential, aiming to create and disrupt markets at scale ([unanimous.vc](https://unanimous.vc/announcing-unanimous-capital-fund-i-lp)). The firm emphasizes trust and supports entrepreneurs developing solutions to meaningful problems, although specific notable portfolio companies are not publicly highlighted ([unanimous.vc](https://unanimous.vc/announcing-unanimous-capital-fund-i-lp)).

W26, a series of LBS Investments I, LP filed for $3.0 million from their LYNNWOOD, WA headquarters, w26 is a series of investments by LBS Investments, LP, a pooled investment fund based in Seattle focused on early-stage ventures ([formds.com](https://www.formds.com/issuers/w23-a-series-of-lbs-investments-lp)). The firm typically invests in innovative startups across sectors such as technology and healthcare, although specific notable portfolio companies are not publicly detailed ([formds.com](https://www.formds.com/issuers/w23-a-series-of-lbs-investments-lp)).

Growth Fund I, a series of CX Ventures, LP filed for $3.0 million from their LYNNWOOD, WA headquarters, growX Ventures Fund I, founded in 2018 and based in Delhi, India, is a venture capital firm that invests in early-stage B2B technology startups across sectors such as fintech, space tech, healthcare, and robotics, leveraging emerging technologies to solve complex problems ([growxventuresfund](https://www.growxventuresfund.com), [growx.vc](https://growx.vc/fund-1)). The firm focuses on providing capital and strategic support to innovative companies, with a strong emphasis on deep tech and industry reshaping solutions ([growx.vc](https://growx.vc/about-us)). Notable portfolio companies include in-space mobility provider Bellatrix and personalized oncology care startup 3BaseCare ([growx.vc](https://growx.vc/about-us)).

Gilgamesh Pharma a Series of What If Ventures Master LLC filed for $1.8 million from their CLAYMONT, DE headquarters, gilgamesh Pharma, a clinical-stage neuroscience biotech, develops innovative, precision psychiatric therapies using AI-powered discovery platforms, focusing on rapid-acting and durable treatments for mental health disorders ([gilgameshpharmaceutical.com](https://www.gilgameshpharmaceutical.com/), [wikipedia.org](https://en.wikipedia.org/wiki/Gilgamesh_Pharmaceuticals)). Its portfolio includes novel chemical entities targeting depression, anxiety, and addiction, with notable programs such as NMDAR antagonists and neuroplastogens ([prnewswire.com](https://www.prnewswire.com/news-releases/gilgamesh-pharmaceuticals-raises-39-million-series-b-to-advance-mental-health-treatments-301704097.html)). The firm emphasizes leveraging advanced neurocircuitry and machine learning to accelerate drug development ([gilgameshpharmaceutical.com/about](https://www.gilgameshpharmaceutical.com/about)).

GVG II a Series of Genius Ventures Growth Fund 0 LLC filed for $1.5 million from their CLAYMONT, DE headquarters, genius Ventures is an early-stage venture capital firm founded in 2024 that focuses on partnering with technical founders building differentiated solutions in sectors such as developer tools, healthcare, fintech, robotics, and enterprise software, providing hands-on operational support and strategic guidance ([f4.fund](https://f4.fund/firms/genius-ventures), [fortune.com](https://fortune.com/2024/04/23/behind-genius-ventures-raises-second-fund-8-million)). Its investment strategy emphasizes backing repeat entrepreneurs solving real problems with teams experienced in scaling at hyperscalers or growth-stage companies ([f4.fund](https://f4.fund/firms/genius-ventures)). Notable portfolio companies are not specified in the available sources.